Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status
Source:
Nasdaq GlobeNewswire
/
07 Aug 2023 15:05:00 America/Chicago
N/A
Share on,